Nirvana Sciences, Inc.

Biotechnology company · Research Triangle Park, North Carolina, United States

Nirvana Sciences, Inc. is a biotechnology company headquartered in Research Triangle Park, North Carolina, United States. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $7.3 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $867,000 sold in a notice filed in 2021.

nirvanasciences.com/nsProfile compiled from public records. Is this your company? Request a correction or update

Nirvana Sciences at a glance

Typebiotechnology company
HeadquartersResearch Triangle Park, North Carolina, United States
Employees (self-reported, 2022)7
SEC CIK1623353

What does Nirvana Sciences do?

US government research funding

7 SBIR/STTR small-business research awards from US health agencies, $7.3 million in total (2014 to 2022). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences, National Cancer Institute.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $867,000 sold (2021).

Frequently asked questions about Nirvana Sciences

Where is Nirvana Sciences headquartered?

Nirvana Sciences, Inc. is headquartered in Research Triangle Park, North Carolina, United States.

What does Nirvana Sciences do?

Nirvana Sciences, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences